FDA Import Refusal 1FX-5648227-7/10002/1 — CIPLA LTD
The FDA refused shipment 1FX-5648227-7/10002/1 from CIPLA LTD (India) on Oct 21, 2026. The refused product falls under Drugs and Biologics — BUDESONIDE (ANTI-ASTHMATIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 21, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61EDY04 BUDESONIDE (ANTI-ASTHMATIC)
- Charges
- 75